文献速递胸部肿瘤

可切除非小细胞肺癌内镜超声阴性后未预见N2病变:确认性纵隔镜检查与否的系统评价与Meta分析

Unforeseen N2 Disease after Negative Endosonography Findings with or without Confirmatory Mediastinoscopy in Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Thorac Oncol · 2019-03-21

该系统评价与Meta分析检索截至2018年9月19日的文献,纳入42项研究或亚组共3248例接受手术参考标准治疗的患者,比较内镜超声阴性后直接手术与先行确认性纵隔镜检查的未预见N2病变率。结果显示两者未预见N2率相似(9.6% vs 9.9%),但纵隔镜检查并发症率为6.0%。

要点

  • 内镜超声阴性后直接手术与先行确认性纵隔镜检查的未预见N2率相似(9.6% vs 9.9%)。
  • 纵隔镜检查并发症率为6.0%,其中喉返神经麻痹占2.8%。
  • 指南建议内镜超声阴性后行确认性纵隔镜检查,但其作用仍在讨论中。

核心结论

  • 内镜超声阴性后直接行肺肿瘤切除的患者与先行确认性纵隔镜检查的患者未预见N2病变率相似,代价是纵隔镜检查6.0%的并发症率。

研究设计与样本

  • 系统评价与Meta分析,检索Medline、Embase和Cochrane数据库截至2018年9月19日,无年份或语言限制。
  • 共发现5073篇文章,最终纳入42项研究或亚组,覆盖3248例接受手术参考标准治疗的患者。
  • 使用诊断准确性研究质量评估工具第2版评价纳入研究的偏倚风险和适用性。

主要发现

  • 内镜超声联合或不联合确认性纵隔镜检查的未预见N2病变率分别为9.6%(95%CI:7.8%-11.7%,I²=30%)与9.9%(95%CI:6.3%-15.2%,I²=73%)。
  • 纵隔镜检查(8项研究,共1245例患者)的随机效应Meta分析显示并发症率为6.0%(95%CI:4.8%-7.5%)。
  • 喉返神经麻痹占2.8%(95%CI:2.0%-4.0%)。

关键数值与推荐

  • 内镜超声阴性后未预见N2病变率:9.6%(95%CI:7.8%-11.7%,I²=30%)。
  • 内镜超声阴性后行确认性纵隔镜检查的未预见N2病变率:9.9%(95%CI:6.3%-15.2%,I²=73%)。
  • 纵隔镜检查并发症率:6.0%(95%CI:4.8%-7.5%);喉返神经麻痹:2.8%(95%CI:2.0%-4.0%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Confirmatory mediastinoscopy after negative endosonography findings is advised by the guidelines on patients with resectable NSCLC and suspected intrathoracic nodes on fludeoxyglucose F 18 positron emission tomography-computed tomography. Its role however is under debate owing to its limited nodal metastasis detection rate, morbidity, associated treatment delay, and unknown impact on survival. METHODS: Systematic review and meta-analysis of studies on invasive mediastinal staging in patients with (suspected) NSCLC. The Medline, Embase, and Cochrane databases were searched until September 19, 2018, without year or language restrictions. The Quality Assessment Tool for Diagnostic Accuracy Studies, version 2, was used to evaluate the risk of bias and applicability of the included studies. Rates of unforeseen N2 disease were assessed for endobronchial ultrasound and/or endoscopic ultrasound staging strategies with or without confirmatory mediastinoscopy. Additionally, the complication rates of cervical video mediastinoscopy for mediastinal staging of NSCLC were investigated. RESULTS: A total of 5073 articles were found, of which 42 studies or subgroups (covering a total of 3248 patients undergoing the surgical reference standard of treatment) were considered in the analysis. Random effects meta-analysis of endosonography with or without confirmatory mediastinoscopy showed rates of unforeseen N2 disease of 9.6% (95% confidence interval [CI]: 7.8%-11.7%, I2 = 30%) versus 9.9% (95% CI: 6.3%-15.2%, I2 = 73%), respectively. Random effects meta-analysis of mediastinoscopy (eight studies [1245 patients in total]) showed a complication rate of 6.0% (95% CI: 4.8%-7.5%), with laryngeal recurrent nerve palsy accounting for 2.8% (95% CI: 2.0%-4.0%). CONCLUSION: The rate of unforeseen N2 disease after negative endosonography findings was similar in patients undergoing immediate lung tumor resection to those undergoing confirmatory mediastinoscopy first, at the cost of 6.0% rate of complications by mediastinoscopy.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Bousema JE, van Dorp M, Noyez VJJM, et al. Unforeseen N2 Disease after Negative Endosonography Findings with or without Confirmatory Mediastinoscopy in Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2019. PMID: 30905829. doi:10.1016/j.jtho.2019.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。